| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13097* | 2021 |
| Acid sphingomyelinase activity triggers microparticle release from glial cells F Bianco, C Perrotta, L Novellino, M Francolini, L Riganti, E Menna, ... The EMBO journal 28 (8), 1043-1054, 2009 | 652 | 2009 |
| Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism F Antonucci, E Turola, L Riganti, M Caleo, M Gabrielli, C Perrotta, ... The EMBO journal 31 (5), 1231-1240, 2012 | 345 | 2012 |
| Endothelial nitric oxide synthase activation by tumor necrosis factor α through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel … C De Palma, E Meacci, C Perrotta, P Bruni, E Clementi Arteriosclerosis, thrombosis, and vascular biology 26 (1), 99-105, 2006 | 212 | 2006 |
| Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy S Brunelli, C Sciorati, G D'Antona, A Innocenzi, D Covarello, BG Galvez, ... Proceedings of the National Academy of Sciences 104 (1), 264-269, 2007 | 179 | 2007 |
| The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation C Perrotta, M Buldorini, E Assi, D Cazzato, C De Palma, E Clementi, ... The American Journal of Pathology 184 (1), 230-247, 2014 | 128 | 2014 |
| Italian cancer figures, report 2012: Cancer in children and adolescents. P Pisani, C Buzzoni, E Crocetti, LD Maso, R Rondelli, D Alessi, M Aricò, ... Epidemiologia e Prevenzione 37, 1-225, 2013 | 122 | 2013 |
| Caspase‐8 and caspase‐7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF‐R1 receptosomes B Edelmann, U Bertsch, V Tchikov, S Winoto‐Morbach, C Perrotta, ... The EMBO journal 30 (2), 379-394, 2011 | 119 | 2011 |
| ITALIAN CANCER FIGURES-REPORT 2015: The burden of rare cancers in Italy= I TUMORI IN ITALIA-RAPPORTO 2015: I tumori rari in Italia S Busco, C Buzzoni, S Mallone, A Trama, M Castaing, F Bella, R Amodio, ... Epidemiologia e prevenzione 40 (1, suppl. 2), 1-120, 2016 | 110 | 2016 |
| Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′, 5′-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of … S Falcone, C Perrotta, C De Palma, A Pisconti, C Sciorati, A Capobianco, ... The Journal of Immunology 173 (7), 4452-4463, 2004 | 106 | 2004 |
| Nitric oxide generated by tumor-associated macrophages is responsible for cancer resistance to cisplatin and correlated with syntaxin 4 and acid sphingomyelinase inhibition C Perrotta, D Cervia, I Di Renzo, C Moscheni, MT Bassi, L Campana, ... Frontiers in immunology 9, 1186, 2018 | 101 | 2018 |
| Activation of endothelial nitric-oxide synthase by tumor necrosis factor-α: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3 … R Barsacchi, C Perrotta, S Bulotta, S Moncada, N Borgese, E Clementi Molecular pharmacology 63 (4), 886-895, 2003 | 98 | 2003 |
| Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic function C Perrotta, L Bizzozero, D Cazzato, S Morlacchi, E Assi, F Simbari, ... Journal of biological chemistry 285 (51), 40240-40251, 2010 | 95 | 2010 |
| Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation C De Palma, F Morisi, S Pambianco, E Assi, T Touvier, S Russo, ... Skeletal muscle 4, 1-21, 2014 | 93 | 2014 |
| Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma C Perrotta, L Bizzozero, S Falcone, P Rovere-Querini, A Prinetti, ... Cancer research 67 (16), 7559-7564, 2007 | 76 | 2007 |
| Italian cancer figures, report 2014: prevalence and cure of cancer in Italy MS Adamo, D Alessi, P Aletta, R Amodio, S Andreone, T Angelin, ... Epidemiologia e prevenzione 38 (6), 1-122, 2014 | 72 | 2014 |
| Autophagy-mediated neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy R Amato, E Catalani, M Dal Monte, M Cammalleri, I Di Renzo, C Perrotta, ... Pharmacological research 128, 167-178, 2018 | 70 | 2018 |
| A novel CLN8 mutation in late‐infantile‐onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function C Vantaggiato, F Redaelli, S Falcone, C Perrotta, A Tonelli, S Bondioni, ... Human mutation 30 (7), 1104-1116, 2009 | 69 | 2009 |
| An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations C Mameli, GV Zuccotti, C Carnovale, E Galli, P Nannini, D Cervia, ... Pharmacological research 119, 99-117, 2017 | 68 | 2017 |
| Skeletal muscle homeostasis in duchenne muscular dystrophy: modulating autophagy as a promising therapeutic strategy C De Palma, C Perrotta, P Pellegrino, E Clementi, D Cervia Frontiers in aging neuroscience 6, 188, 2014 | 68 | 2014 |
